Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pneumonologia I Alergologia Polska|August 1, 2002
[P53 and P16 gene mutations in non-small cell lung cancer]Ewa Jassem, Rodryg Ramlau, Rafał Dziadziuszko, et al.International Archives of Allergy and Immunology|July 3, 2008
Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapyLucyna Gorska, Marta Chelminska, Krzysztof Kuziemski, et al.Pneumonologia I Alergologia Polska|April 24, 2003
[Serum anti-P53 antibodies (AB-anti-P53) in patients with advanced non-small cell lung cancer (NSCLC)]Marcin Skrzypski, Amelia Szymanowska, Anna Janowicz, et al.Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)Dorota Dworakowska, Ewa Jassem, Jacek Jassem, et al.Journal of Thoracic Disease|January 12, 2026
Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosisDragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, et al.Clinical Lung Cancer|July 23, 2013
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genesMarcin Skrzypski, Rafał Dziadziuszko, Ewa Jassem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expressionRafal Dziadziuszko, Daniel T Merrick, Samir E Witta, et al.Plos One|November 8, 2007
BRCA1: a novel prognostic factor in resected non-small-cell lung cancerRafael Rosell, Marcin Skrzypski, Ewa Jassem, et al.Pageof 2